These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28543352)

  • 1. Effect of Albiglutide on Cholecystokinin-Induced Gallbladder Emptying in Healthy Individuals: A Randomized Crossover Study.
    Shaddinger BC; Young MA; Billiard J; Collins DA; Hussaini A; Nino A
    J Clin Pharmacol; 2017 Oct; 57(10):1322-1329. PubMed ID: 28543352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.
    Keller J; Trautmann ME; Haber H; Tham LS; Hunt T; Mace K; Linnebjerg H
    Regul Pept; 2012 Nov; 179(1-3):77-83. PubMed ID: 22960288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
    Rohde U; Sonne DP; Christensen M; Hansen M; Brønden A; Toräng S; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2016 May; 101(5):2076-83. PubMed ID: 27003305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.
    Rehfeld JF; Knop FK; Asmar A; Madsbad S; Holst JJ; Asmar M
    Scand J Gastroenterol; 2018 Dec; 53(12):1429-1432. PubMed ID: 30449207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
    Brønden A; Albér A; Rohde U; Gasbjerg LS; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2018 Feb; 20(2):362-369. PubMed ID: 28786523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study.
    Hansen NL; Brønden A; Nexøe-Larsen CC; Christensen AS; Sonne DP; Rehfeld JF; Wever Albretchsen NJ; Hartmann B; Vilsbøll T; Holst JJ; Knop FK
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00257. PubMed ID: 33512799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
    Brønden A; Albér A; Rohde U; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4153-4162. PubMed ID: 28938439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous glucagon-like peptide 2 counteracts exogenous cholecystokinin-induced gallbladder contraction in healthy men.
    Lange AH; Hansen NL; Pedersen MG; Nerild HH; Rehfeld JF; Hartmann B; Holst JJ; Ellegaard AM; Knop FK
    J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38888179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic cholescintigraphy: induction and description of gallbladder emptying.
    Toftdahl DB; Højgaard L; Winkler K
    J Nucl Med; 1996 Feb; 37(2):261-6. PubMed ID: 8667057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder emptying during high-dose cholecystokinin infusions. Effect in patients with gallstone disease and healthy controls.
    Pauletzki J; Cicala M; Spengler U; Sauerbruch T; Paumgartner G
    Scand J Gastroenterol; 1995 Feb; 30(2):128-32. PubMed ID: 7732334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tegaserod does not alter fasting or meal-induced biliary tract motility.
    Fisher RS; Thistle J; Lembo A; Novick J; O'Kane P; Chey WD; Beglinger C; Rueegg P; Shi V; Dogra A; Luo D; Earnest DL
    Am J Gastroenterol; 2004 Jul; 99(7):1342-9. PubMed ID: 15233676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Avenues in the Regulation of Gallbladder Motility-Implications for the Use of Glucagon-Like Peptide-Derived Drugs.
    Gether IM; Nexøe-Larsen C; Knop FK
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2463-2472. PubMed ID: 30137354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sequential administration of an opioid and cholecystokinin on gallbladder ejection fraction: brief communication.
    Krishnamurthy S; Krishnamurthy GT
    J Nucl Med; 2006 Sep; 47(9):1463-6. PubMed ID: 16954554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Double-Blind, Single-Dose, Crossover Study to Demonstrate the Bioequivalence of 2 Formulations of Albiglutide in Healthy Adult Participants.
    Shaddinger BC; Vlasakakis G; Soffer J; Thorpe KM; Hatch D; Nino AJ
    Clin Pharmacol Drug Dev; 2019 Apr; 8(3):361-370. PubMed ID: 30063297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on CCK-induced gallbladder emptying with real-time ultrasonography].
    Wang Z; Wu J; Miao X
    Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):385-7. PubMed ID: 8582185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single and multiple administrations of cisapride on postprandial gallbladder emptying in healthy humans.
    Takaoka M; Kubota Y; Fujimura K; Ogura M; Kin H; Yamamoto S; Inoue K
    Intern Med; 1994 Jul; 33(7):381-6. PubMed ID: 7949636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albiglutide for the management of type 2 diabetes.
    Rendell MS
    Expert Rev Endocrinol Metab; 2018 Jan; 13(1):1-8. PubMed ID: 30063441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vapreotide, a somatostatin analogue, on gastric acidity, gallbladder emptying and hormone release after 1 week of continuous subcutaneous infusion in normal subjects.
    Ritz MA; Drewe J; Ziel A; Hildebrand P; Schneider P; Lahlou N; Beglinger C
    Br J Clin Pharmacol; 1999 Feb; 47(2):195-201. PubMed ID: 10190655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus.
    Davis PN; Ndefo UA; Oliver A; Payton E
    Am J Health Syst Pharm; 2015 Jul; 72(13):1097-103. PubMed ID: 26092960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.